EN
Press Releases
-
BEIJING, China, December 29, 2022 -- Sinovac Biotech Ltd. (NASDAQ: SVA) ("SINOVAC" or the "Company"), a leading provider of biopharmaceutical products in China, announced today its
-
2022/12/21
SINOVAC's COVID-19 Vaccine Obtains the Official Pharmaceutical Product Registration in Hong Kong
December 20, 2022, Hong Kong -- Sinovac Biotech Ltd. ("SINOVAC" or the "Company") (NASDAQ: SVA), a leading provider of biopharmaceutical products in China, announced that its COVID
-
December 6, 2022, Jakarta -- Sinovac Biotech Ltd. ("SINOVAC" or the "Company") (NASDAQ: SVA), a leading provider of biopharmaceutical products in China, announced that its inactiva
-
2022/11/29
SINOVAC Quadrivalent Influenza Vaccine Authorized for Commercialization in the Dominican Republic
November 29, 2022, Beijing -- Sinovac Biotech Ltd. ("SINOVAC" or the "Company") (NASDAQ: SVA), a leading provider of biopharmaceutical products in China, announced that its quadriv
-
2022/11/22
WHO Extended the Use of SINOVAC COVID-19 Vaccine under EUL to Individuals Aged 3 Years and Above
![WHO Extended the Use of SINOVAC COVID-19 Vaccine under EUL to Individuals Aged 3 Years and Above]()
November 22, 2022, Beijing -- Sinovac Biotech Ltd. ("SINOVAC" or the "Company") (NASDAQ: SVA), a leading provider of biopharmaceutical products in China, announced that its COVID-1
-
![SINOVAC's EV71 Vaccine Inlive<sup>®</sup> Approved in Indonesia]()
November 18, 2022, Jakarta -- Sinovac Biotech Ltd. ("SINOVAC" or the "Company") (NASDAQ: SVA), a leading provider of biopharmaceutical products in China,
-
![SINOVAC Donates 100,000 Doses of Hepatitis A Vaccines to Pakistan]()
November 9, 2022, Islamabad -- Sinovac Biotech Ltd. ("SINOVAC" or the "Company") (NASDAQ: SVA), a leading provider of biopharmaceutical products in China, announced that the Compan
-
![SINOVAC Varicella Vaccine Prequalified by WHO]()
November 4, 2022, Beijing -- Sinovac Biotech Ltd. ("SINOVAC" or the "Company") (NASDAQ: SVA), a leading provider of biopharmaceutical products in China, today announced that it rec
-
![SINOVAC to Showcase Products at CPHI Frankfurt]()
October 28th, 2022, Beijing -- Sinovac Biotech Ltd. (“SINOVAC” or the “Company”) (NASDAQ: SVA), a leading provider of biopharmaceutical products in China, announced that the Company will participate i
-
![SINOVAC-Sponsored Automated Complex for Vaccine Storage and Distribution is Delivered to the Egyptian]()
On September 24, the handover ceremony of the Chinese government's donation of COVID-19 vaccine to Egyptian women, children, and adolescents & the delivery ceremony of SINOVAC's sponsored
-
October 21, 2022, Beijing -- Sinovac Biotech Ltd. ("SINOVAC" or the "Company") (NASDAQ: SVA), a leading provider of biopharmaceutical products in China, announced today that the Co
-
![SINOVAC Quadrivalent Influenza Vaccine Is Authorized For Marketing Use in Bangladesh]()
SINOVAC's quadrivalent influenza vaccine collaborated with a local partner has been approved by the Directorate General of Drug Administration (DGDA) in Bangladesh for marketing use recently. This
-
2022/09/06
SINOVAC Approved to Initiate Clinical Trial for Its Omicron Containing COVID-19 Vaccine in Chile
![SINOVAC Approved to Initiate Clinical Trial for Its Omicron Containing COVID-19 Vaccine in Chile]()
September 6, 2022, Beijing -- Sinovac Biotech Ltd. ("SINOVAC" or the "Company") (NASDAQ: SVA), a leading provider of biopharmaceutical products in China, announced that the Chilean
-
![SINOVAC COVID-19 Vaccine Approved for Use in Children 6 Months and Older in Chile]()
August 25, 2022, Beijing -- Sinovac Biotech Ltd. ("SINOVAC" or the "Company") (NASDAQ: SVA), a leading provider of biopharmaceutical products in China, announced that the Chilean P
-
![Sinovac Beijing's QC Laboratory Accredited By CNAS]()
August 20, 2022, Beijing – Sinovac Biotech Ltd. (NASDAQ: SVA) ("SINOVAC" or the "Company"), a leading provider of biopharmaceutical products in China, today announced that the Qual
-
August 3, 2022, Beijing -- Sinovac Biotech Ltd. ("SINOVAC" or the "Company") (NASDAQ: SVA), a leading provider of biopharmaceutical products in China, announced that based on relat
-
July 19, 2022, Beijing -- Sinovac Biotech Ltd. ("SINOVAC" or the "Company") (NASDAQ: SVA), a leading provider of biopharmaceutical products in China, announced that a phase III cli
-
July 14, 2022, Beijing -- Sinovac Biotech Ltd. ("SINOVAC" or the "Company") (NASDAQ: SVA), a leading provider of biopharmaceutical products in China, announced that its COVID-19 va
-
HONG KONG--A kick off ceremony was held at Gleneagles Hospital Hong Kong (Gleneagles or GHK) for initiating a clinical trial to assess the safety and immunogenicity of the SINOVAC’s Omicron-specific C
-
![SINOVAC COVID-19 Vaccine Is Conditionally Registered In South Africa]()
Sinovac Biotech Ltd. (NASDAQ: SVA) ("SINOVAC" or the "Company"), a leading provider of biopharmaceutical products in China, today announced that the South African Health Products R
